Literature DB >> 10369918

MIC-A allele profiles and HLA class I associations in Behçet's disease.

G R Wallace1, D H Verity, L J Delamaine, S Ohno, H Inoko, M Ota, N Mizuki, K Yabuki, E Kondiatis, H A Stephens, W Madanat, C A Kanawati, M R Stanford, R W Vaughan.   

Abstract

Recently a new family of non-classical MHC molecules, the MHC class I chain-related protein (MIC), encoded by genes located in the major histocompatability complex have been identified. On the basis of the location of MIC genes and the structure and expression of MIC molecules it has been postulated that MIC may be a susceptibility factor in Behçet's disease (BD). We investigated the association of the 16 described external domain alleles and the transmembrane triplet repeats of MIC-A with BD in a Middle Eastern population. DNA from ninety-five patients and 102 age- and sex-matched controls were analyzed by polymerase chain reaction using allele specific primers. Our results show an increase of MIC-A*009 in the BD patient group 44/95 (46%) compared with controls 24/102 (24%) (chi2=11.3, OR=2.8, P=0.00078). MIC-A*009 was also found to be strongly associated with HLA-B51 in the patients 39/44 (88%) when compared with controls 10/24 (42%) (chi2=4, P=0.04). MIC-A*009 was also found in linkage disequilibrium with HLA-B52, but only in controls. The A6 form of a MIC-A transmembrane triplet repeat was found to be significantly raised in the patients (80/95; 84%;) compared with controls (58/102, 57%) (chi2=17.5, OR=4, P=0.000028). Although the MIC-A associations described are highly significant, the association with HLA-B51 independently remains the most significant factor (chi2=56.8, P<10(-6)). The data suggests that as both MIC-A*009 and A6 are in strong linkage disequilibrium with HLA-B51, they are unlikely to be the susceptibility gene for BD but may be markers for additional risk factors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369918     DOI: 10.1007/s002510050656

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  16 in total

1.  High-density map of short tandem repeats across the human major histocompatibility complex.

Authors:  Michael Cullen; Michael Malasky; Anita Harding; Mary Carrington
Journal:  Immunogenetics       Date:  2003-02-21       Impact factor: 2.846

Review 2.  Behçet's disease: from Hippocrates to the third millennium.

Authors:  D H Verity; G R Wallace; R W Vaughan; M R Stanford
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

3.  Molecular mechanisms in Behçet's disease.

Authors:  R Rajendram; N A Rao
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

4.  An NKG2D-mediated human lymphoid stress surveillance response with high interindividual variation.

Authors:  Seema Shafi; Pierre Vantourout; Graham Wallace; Ayman Antoun; Robert Vaughan; Miles Stanford; Adrian Hayday
Journal:  Sci Transl Med       Date:  2011-11-30       Impact factor: 17.956

5.  HLA-B51 gene and its expression in association with Behçet's Disease in Denizli Province of Turkey.

Authors:  Ayfer Atalay; Sanem Yildiz-Demirtepe; Sinan Tatlipinar; Berna Sanli-Erdoğan; Veli Cobankara; Cem Yildirim; Hüseyin Bağci; Erol Omer Atalay
Journal:  Mol Biol Rep       Date:  2007-06-27       Impact factor: 2.316

6.  Association of Major Histocompatibility Complex Class I Chain-Related Gene A and HLA-B Alleles with Behçet's Disease in Turkey.

Authors:  Nobuko Mizuki; Akira Meguro; Iwai Tohnai; Ahmet Gül; Shigeaki Ohno; Nobuhisa Mizuki
Journal:  Jpn J Ophthalmol       Date:  2007-12-21       Impact factor: 2.447

7.  Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.

Authors:  Sarah Samandary; Hédia Kridane-Miledi; Jacqueline S Sandoval; Zareen Choudhury; Francina Langa-Vives; Doran Spencer; Aziz A Chentoufi; François A Lemonnier; Lbachir BenMohamed
Journal:  Hum Immunol       Date:  2014-05-04       Impact factor: 2.850

8.  HLA-B*51 the primary risk in Behçet disease.

Authors:  Graham R Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-29       Impact factor: 11.205

9.  A genetic risk score for thyroid peroxidase antibodies associates with clinical thyroid disease in community-based populations.

Authors:  Ulla T Schultheiss; Alexander Teumer; Marco Medici; Yong Li; Natalie Daya; Layal Chaker; Georg Homuth; Andre G Uitterlinden; Matthias Nauck; Albert Hofman; Elizabeth Selvin; Henry Völzke; Robin P Peeters; Anna Köttgen
Journal:  J Clin Endocrinol Metab       Date:  2015-02-26       Impact factor: 5.958

10.  Association of MICA Alleles and Human Leukocyte Antigen B in Turkish Patients Diagnosed With Behçet's Disease.

Authors:  Nilnur Eyerci; Eda Balkan; Necmettin Akdeniz; Sadullah Keleş
Journal:  Arch Rheumatol       Date:  2018-01-31       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.